Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights

Emily Latacz, Diederik Höppener, Ali Bohlok, Sophia Leduc, Sébastien Tabariès, Carlos Fernández Moro, Claire Lugassy, Hanna Nyström, Béla Bozóky, Giuseppe Floris, Natalie Geyer, Pnina Brodt, Laura Llado, Laura Van Mileghem, Maxim De Schepper, Ali W Majeed, Anthoula Lazaris, Piet Dirix, Qianni Zhang, Stéphanie K Petrillo, Sophie Vankerckhove, Ines Joye, Yannick Meyer, Alexander Gregorieff, Nuria Ruiz Roig, Fernando Vidal-Vanaclocha, Larsimont Denis, Rui Caetano Oliveira, Peter Metrakos, Dirk J Grünhagen, Iris D Nagtegaal, David G Mollevi, William R Jarnagin, Michael I D'Angelica, Andrew R Reynolds, Michail Doukas, Christine Desmedt, Luc Dirix, Vincent Donckier, Peter M Siegel, Raymond Barnhill, Marco Gerling, Cornelis Verhoef, Peter B Vermeulen, Emily Latacz, Diederik Höppener, Ali Bohlok, Sophia Leduc, Sébastien Tabariès, Carlos Fernández Moro, Claire Lugassy, Hanna Nyström, Béla Bozóky, Giuseppe Floris, Natalie Geyer, Pnina Brodt, Laura Llado, Laura Van Mileghem, Maxim De Schepper, Ali W Majeed, Anthoula Lazaris, Piet Dirix, Qianni Zhang, Stéphanie K Petrillo, Sophie Vankerckhove, Ines Joye, Yannick Meyer, Alexander Gregorieff, Nuria Ruiz Roig, Fernando Vidal-Vanaclocha, Larsimont Denis, Rui Caetano Oliveira, Peter Metrakos, Dirk J Grünhagen, Iris D Nagtegaal, David G Mollevi, William R Jarnagin, Michael I D'Angelica, Andrew R Reynolds, Michail Doukas, Christine Desmedt, Luc Dirix, Vincent Donckier, Peter M Siegel, Raymond Barnhill, Marco Gerling, Cornelis Verhoef, Peter B Vermeulen

Abstract

The first consensus guidelines for scoring the histopathological growth patterns (HGPs) of liver metastases were established in 2017. Since then, numerous studies have applied these guidelines, have further substantiated the potential clinical value of the HGPs in patients with liver metastases from various tumour types and are starting to shed light on the biology of the distinct HGPs. In the present guidelines, we give an overview of these studies, discuss novel strategies for predicting the HGPs of liver metastases, such as deep-learning algorithms for whole-slide histopathology images and medical imaging, and highlight liver metastasis animal models that exhibit features of the different HGPs. Based on a pooled analysis of large cohorts of patients with liver-metastatic colorectal cancer, we propose a new cut-off to categorise patients according to the HGPs. An up-to-date standard method for HGP assessment within liver metastases is also presented with the aim of incorporating HGPs into the decision-making processes surrounding the treatment of patients with liver-metastatic cancer. Finally, we propose hypotheses on the cellular and molecular mechanisms that drive the biology of the different HGPs, opening some exciting preclinical and clinical research perspectives.

Conflict of interest statement

The authors declare no competing interests.

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Figures

Fig. 1. The histopathological growth patterns of…
Fig. 1. The histopathological growth patterns of liver metastases (H&E images).
a Low-magnification image of a CRC liver metastasis with a desmoplastic HGP. b, c Higher magnification of the tumour–liver interface of CRC liver metastases with a desmoplastic HGP. The blue double-headed arrow indicates the desmoplastic rim that separates the carcinoma from the liver parenchyma. The green arrowheads indicate the immune cell infiltrate which is typically located at the transition between the desmoplastic rim and the liver parenchyma. The tumours show glandular differentiation and cell detritus in the lumina of these glandular structures, reminiscent of the histology of a primary CRC (white arrowheads). d Low-magnification image of a CRC liver metastasis with a replacement HGP. The green arrowheads indicate the tumour–liver interface. There is no glandular differentiation: cancer cells from solid nests and trabeculae. e, f Higher magnification of the tumour–liver interface of CRC liver metastases with a replacement HGP. The green arrowheads indicate contact between cancer cells and hepatocytes. In (e), cancer cells form cell plates that are in continuity with the liver cell plates. A co-opted sinusoidal blood vessel is marked by the blue arrowheads. In (f), the liver cell plates are pushed aside but cancer cells are still in contact with hepatocytes while invading into these liver cell plates (green arrowheads). g Low-magnification image of a CRC liver metastasis with a pushing HGP. h On higher magnification, a sharp tumour–liver interface is noticed without desmoplastic rim and without cancer cells invading into the liver parenchyma. Often metastases with a pushing HGP produce mucin, as shown in this example. i Lobular breast carcinoma liver metastasis with a sinusoidal HGP (autopsy case). Cancer cells are located within the lumen of sinusoidal blood vessels (green asterisks), in between liver cell plates (blue asterisks). Red blood cells are intermingled with the cancer cells (blue arrowheads). j Low-magnification image of intrabiliary tumour growth (CRC) in a portal tract. The structures constituting a portal tract are present: artery branches (A), vein branch (V), nerve bundle (N) and branches of the bile duct (B), in this case filled with cancer cells. k Higher magnification of the left bile duct branch of image J. The normal bile duct epithelium (blue arrowheads) is still present but is replaced by cancer tissue that fills the lumen of the bile duct branch.
Fig. 2. Survival of patients with colorectal…
Fig. 2. Survival of patients with colorectal liver metastases according to different cut-off values for histopathological growth patterns.
Kaplan–Meier curves depicting overall and disease-free survival of patients with colorectal liver metastases, stratified by the new cut-off for histopathological growth patterns categorisation (ad) and by the predominant growth pattern (e, f). N = 1931 patients with resected colorectal liver metastases.
Fig. 3. H&E image of the escape…
Fig. 3. H&E image of the escape phenotype.
a Low-magnification image with large necrotic areas in the centre of the CRC liver metastasis, remnants of the desmoplastic rim (D) and vital replacement-type outgrowth at the tumour–liver interface (arrows). This is a ‘halo’ of vital cancer infiltrating the liver tissue for several millimetres at the periphery of the metastasis, with signs of response in its centre. b Higher magnification of the ‘escape’ area with replacement HGP. Li liver, Me metastatic tumour tissue.
Fig. 4. Immunohistochemical staining as an aid…
Fig. 4. Immunohistochemical staining as an aid to HGP scoring.
a Detection of the replacement HGP in the presence of an extensive immune cell infiltrate that obscures the tumour–liver interface by identification of cancer cell-hepatocyte contact (green arrowheads) at the tumour–liver interface and co-option of hepatocytes (blue arrowheads) in liver lobules undergoing replacement by cancer cells. CK19 (DAB, brown) stains colorectal cancer cells. CK18 (AP, red) stains hepatocytes. Left: low magnification; right: high magnification. b Detection of the pushing-type replacement (type 2) HGP in which the hepatocyte plates are slender (yellow dotted area) and arranged in parallel with the tumour–liver interface. Green arrowheads indicate cancer cell-hepatocyte contact and blue arrowheads hepatocyte co-option. CK19 (DAB, brown) stains colorectal cancer cells. CK18 (AP, red) stains hepatocytes. c Prominent ductular reaction at the tumour–liver interface in the desmoplastic HGP. Areas of ductular reaction (green arrowheads) are present in the outer region of the fibrous rim (green dotted region). Cancer cells are (blue arrow) identified in the metastasis centre, adjacent to necrotic areas (orange star). Right: Detail of the ductular reaction at the tumour–liver interface. Cholangiocytes (CK7 + ) form irregular, angulated, anastomosing ductuli. Note the presence of interspersed cancer cells (CK20 + , blue arrows) within the ductuli, forming common ductular structures. CK20 (DAB, brown) stains colorectal cancer cells. CK7 (AP, red) stains cholangiocytes. d Detection of intrabiliary tumour growth. A discontinuous lining of biliary epithelial cells (blue arrows) can be identified surrounding colorectal cancer cells (sparsely positive for CK20 in this case) with focal contact between colorectal cancer cells and biliary epithelial cells (green stars). CK20 (DAB, brown) stains colorectal cancer cells. CK7 (AP, red) stains cholangiocytes. Left: low magnification; right: high magnification.
Fig. 5. Patient-derived xenograft (PDX) mice models…
Fig. 5. Patient-derived xenograft (PDX) mice models for CRC liver metastases with a desmoplastic and a replacement HGP (H&E images).
a Resected liver metastasis with a desmoplastic HGP (left) and corresponding xenograft PDX model (right). Green arrows indicate the desmoplastic rim in the patient sample and in the liver metastasis of the mouse (PDX#35, see supplementary table 2 in ref. [16]). b Resected liver metastasis with a replacement HGP (left) and corresponding xenograft PDX model (Right). Green arrows indicate some of the areas in which the cancer cells grow into the liver cell plates and contact the hepatocytes, both in the patient sample and in the liver metastasis of the mouse (PDX#30, see supplementary table 2 in ref. [16]).
Fig. 6. Images of melan-A immunostaining of…
Fig. 6. Images of melan-A immunostaining of melanoma liver metastases.
a High-magnification images of the tumour–liver interface of a melanoma liver metastasis with a replacement HGP. Small groups of melanoma cells and individual melanoma cells have migrated away from the tumour–liver interface (arrows). b High-magnification images of the tumour–liver interface of a melanoma liver metastasis with a desmoplastic HGP. No migration of melanoma cells in the desmoplastic rim, marked by ‘D’.
Fig. 7. New biological insights into growth…
Fig. 7. New biological insights into growth patterns through immunohistochemical analyses.
a Remnants of portal zones in the centre of colorectal liver metastases. Left: Detail of a tumour centre in metastasis with a predominant replacement HGP showing remnant of a portal zone with bile duct (green arrowhead) and hepatic artery branch (blue arrowhead). Note colonisation by viable cancer cells of the periportal limiting plate region (orange arrowhead). Caldesmon (DAB, brown) stains smooth muscle cells, mainly in the media layer of the hepatic artery. CK7 (DAB, brown) stains bile duct epithelium. CD34 (AP, red) stains the endothelium of the hepatic artery and of the stromal capillary network. Right: Tumour centre in metastasis with a desmoplastic HGP showing multiple remnants of portal zones between lobules that have undergone complete replacement by cancer cells (orange arrowheads). The bile ducts (green arrows) and branches of the hepatic artery (blue arrows) are embedded in NGFR + portal stroma (yellow arrowheads). CD146 (DAB, brown) stains smooth muscle cells (mainly in the wall of hepatic arteries) and areas of ductular reaction. NGFR (AP, red) stains activated portal fibroblasts and stellate cells. b Intrabiliary tumour growth in a CRC liver metastasis. Left: Densely packed cancer cells (green stars) show exophytic growth and fill the bile duct lumen. Portions of the preserved biliary epithelium (blue arrows) are still identified. Right: Detail illustrating the replacement-like growth of cancer cells, which progress by establishing direct contact with and replacing the cholangiocytes while co-opting their basal membrane. CK20 (DAB, brown) stains colorectal cancer cells. CK7 (AP, red) stains cholangiocytes. c Hybrid cancer cell–cholangiocyte ductular structures. Ductular reaction in the desmoplastic rim with cancer cells (CK20-positive, DAB, brown) forming hybrid structures with cholangiocytes (CK7-positive, AP, red). d Stromal cell heterogeneity in metastasis with a desmoplastic HGP. Top. The outer region of the desmoplastic rim stains strongly positively for NGFR (left, green arrows) and α-smooth muscle actin (alpha-SMA) (Right, green arrowheads), consistent with activated portal/stellate cell stroma. In contrast, the stroma in the metastasis centre is positive for alpha-SMA but negative for NGFR, indicating a desmoplastic character (left and right, blue arrows). Bottom. Reference illustrations of activated portal stroma in the non-neoplastic liver, showing (left) NGFR and (right) alpha-SMA immunoreactivity (left and right, green arrows). CD146 (DAB, brown) stains vascular and sinusoidal endothelium and smooth muscle in branches of the hepatic artery and portal vein. NGFR (AP, red) stains activated portal fibroblasts and stellate cells. CK18 (DAB, brown) stains hepatocytes and cholangiocytes. Alpha-SMA (AP, red) stains activated portal fibroblasts, stellate cells and desmoplasia-associated myofibroblasts. e Ductular reaction in the desmoplastic rim with cells with a hepatocyte-like (CK18-positive, AP, red) and a cholangiocytes-like (CK18, DAB, brown) phenotype (green arrows).

References

    1. van Dam PJ, van der Stok EP, Teuwen LA, Van den Eynden GG, Illemann M, Frentzas S, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br J Cancer. 2017;117:1427–41.
    1. Stremitzer S, Vermeulen P, Graver S, Kockx M, Dirix L, Yang D, et al. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. Br J Cancer. 2020;122:1518–24.
    1. Liang JY, Xi SY, Shao Q, Yuan YF, Li BK, Zheng Y, et al. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy. Cancer Immunol Immunother. 2020;69:2623–34.
    1. Hoppener DJ, Nierop PMH, Hof J, Sideras K, Zhou G, Visser L, et al. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis. Br J Cancer. 2020;123:196–206.
    1. Watanabe K, Mitsunaga S, Kojima M, Suzuki H, Irisawa A, Takahashi H, et al. The “histological replacement growth pattern” represents aggressive invasive behavior in liver metastasis from pancreatic cancer. Cancer Med. 2020;9:3130–41.
    1. Messaoudi N, Henault D, Stephen D, Cousineau I, Simoneau E, Rong Z, et al. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns. Br J Cancer. 2022;126:1329–38.
    1. Gulia S, Khurana S, Shet T, Gupta S. Radiographically occult intrasinusoidal liver metastases leading to hepatic failure in a case of breast cancer. BMJ Case Rep. 2016;2016:bcr2015214120.
    1. Cheng J, Wei J, Tong T, Sheng W, Zhang Y, Han Y, et al. Prediction of histopathologic growth patterns of colorectal liver metastases with a noninvasive imaging method. Ann Surg Oncol. 2019;26:4587–98.
    1. Han Y, Chai F, Wei J, Yue Y, Cheng J, Gu D, et al. Identification of predominant histopathological growth patterns of colorectal liver metastasis by multi-habitat and multi-sequence based radiomics analysis. Front Oncol. 2020;10:1363.
    1. Starmans MPA, Buisman FE, Renckens M, Willemssen F, van der Voort SR, Groot Koerkamp B, et al. Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study. Clin Exp Metastasis. 2021;38:483–94.
    1. Alzubi MA, Sohal SS, Sriram M, Turner TH, Zot P, Idowu M, et al. Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts. Clin Exp Metastasis. 2019;36:257–69.
    1. Piquet L, Dewit L, Schoonjans N, Millet M, Berube J, Gerges PRA. et al. Synergic interactions between hepatic stellate cells and uveal melanoma in metastatic growth. Cancers. 2019;11:1043.
    1. Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernandez-Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359:920–6.
    1. Ibrahim NS, Lazaris A, Rada M, Petrillo SK, Huck L, Hussain S, et al. Angiopoietin1 deficiency in hepatocytes affects the growth of colorectal cancer liver metastases (CRCLM). Cancers. 2019;12:35.
    1. Masaki S, Hashimoto Y, Kunisho S, Kimoto A, Kitadai Y. Fatty change of the liver microenvironment influences the metastatic potential of colorectal cancer. Int J Exp Pathol. 2020;101:162–70.
    1. Tabaries S, Annis MG, Lazaris A, Petrillo SK, Huxham J, Abdellatif A, et al. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern. Commun Biol. 2021;4:657.
    1. Bartlett AQ, Pennock ND, Klug A, Schedin P. Immune milieu established by postpartum liver involution promotes breast cancer liver metastasis. Cancers. 2021;13:1698.
    1. Galjart B, Nierop PMH, van der Stok EP, van den Braak R, Hoppener DJ, Daelemans S, et al. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Angiogenesis. 2019;22:355–68.
    1. Hoppener DJ, Galjart B, Nierop PMH, Buisman FE, van der Stok EP, Coebergh van den Braak RRJ, et al. Histopathological growth patterns and survival after resection of colorectal liver metastasis: an external validation study. JNCI Cancer Spectr. 2021;5:pkab026.
    1. Zhaoyang X, Carlos Fernádez M, Danyil K, Béla B, Le D, Qianni Z. Tissue region growing for hispathology image segmentation. In: Proceedings of the 2018 3rd International Conference on Biomedical Imaging, Signal Processing. Bari, Italy: Association for Computing Machinery; 2018.
    1. Tellez D, Höppener D, Verhoef C, Grünhagen D, Nierop P, Drozdzal M, et al. Extending unsupervised neural image compression with supervised multitask learning. Proc Mach Learn Res. 2020;121:770–83.
    1. Tellez D, Litjens G, van der Laak J, Ciompi F. Neural image compression for gigapixel histopathology image analysis. IEEE Trans Pattern Anal Mach Intell. 2021;43:567–78.
    1. Nierop PMH, Galjart B, Hoppener DJ, van der Stok EP, Coebergh van den Braak RRJ, Vermeulen PB, et al. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns. Clin Exp Metastasis. 2019;36:109–18.
    1. Nierop PMH, Hoppener DJ, van der Stok EP, Galjart B, Buisman FE, Balachandran VP, et al. Histopathological growth patterns and positive margins after resection of colorectal liver metastases. HPB. 2020;22:911–9.
    1. Buisman FE, Van der Stok EP, Galjart B, Vermeulen PB, Balachandran VP, Coebergh van den Braak RRJ, et al. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases. Clin Exp Metastasis. 2020;37:593–605.
    1. Masson P. Les tumeurs. Traité De Pathologie Et Thérapie Appliquées. 1923;27:572–4.
    1. Hamperl H. Die morphologie der tumoren. Lehrb Der Allgemeinen Pathologie Und Der Pathologischen Anat. 1956;6:243–4.
    1. Elias H, Bouldin RF. Reaction of the normal liver parenchyma to metastatic carcinoma. Acta Hepatosplenol. 1962;9:357–86.
    1. Elias H, Bierring F, Grunnet I. Cellular changes in the vicinity of metastatic carcinoma, observed by light and electron microscopy. Oncologia. 1964;18:210–24.
    1. Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol. 2001;195:336–42.
    1. Latacz E, Caspani E, Barnhill R, Lugassy C, Verhoef C, Grunhagen D, et al. Pathological features of vessel co-option versus sprouting angiogenesis. Angiogenesis. 2020;23:43–54.
    1. van Dam PJ, Daelemans S, Ross E, Waumans Y, Van Laere S, Latacz E, et al. Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy. Semin Cancer Biol. 2018;52:86–93.
    1. Lugassy C, Kleinman HK, Vermeulen PB, Barnhill RL. Angiotropism, pericytic mimicry and extravascular migratory metastasis: an embryogenesis-derived program of tumor spread. Angiogenesis. 2020;23:27–41.
    1. Allison KH, Fligner CL, Parks WT. Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases. Arch Pathol Lab Med. 2004;128:1418–23.
    1. Simone C, Murphy M, Shifrin R, Zuluaga Toro T, Reisman D. Rapid liver enlargement and hepatic failure secondary to radiographic occult tumor invasion: two case reports and review of the literature. J Med Case Rep. 2012;6:402.
    1. Watson AJ. Diffuse intra-sinusoidal metastatic carcinoma of the liver. J Pathol Bacteriol. 1955;69:207–17.
    1. Vaideeswar P, Munot S, Rojekar A, Deodhar K. Hepatic diffuse intra-sinusoidal metastases of pulmonary small-cell carcinoma. J Postgrad Med. 2012;58:230–1.
    1. Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris AL, et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer. 2004;90:1429–36.
    1. Hoppener DJ, Nierop PMH, Herpel E, Rahbari NN, Doukas M, Vermeulen PB, et al. Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy. Clin Exp Metastasis. 2019;36:311–9.
    1. Terayama N, Terada T, Nakanuma Y. Histologic growth patterns of metastatic carcinomas of the liver. Jpn J Clin Oncol. 1996;26:24–9.
    1. Frentzas S, Simoneau E, Bridgeman VL, Vermeulen PB, Foo S, Kostaras E, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22:1294–302.
    1. Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, et al. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients. NPJ Breast Cancer. 2020;6:64.
    1. Horn SR, Stoltzfus KC, Lehrer EJ, Dawson LA, Tchelebi L, Gusani NJ, et al. Epidemiology of liver metastases. Cancer Epidemiol. 2020;67:101760.
    1. Barnhill R, Vermeulen P, Daelemans S, van Dam PJ, Roman-Roman S, Servois V, et al. Replacement and desmoplastic histopathological growth patterns: a pilot study of prediction of outcome in patients with uveal melanoma liver metastases. J Pathol Clin Res. 2018;4:227–40.
    1. Barnhill R, van Dam PJ, Vermeulen P, Champenois G, Nicolas A, Rawson RV, et al. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value. J Pathol Clin Res. 2020;6:195–206.
    1. Grossniklaus HE, Zhang Q, You S, McCarthy C, Heegaard S, Coupland SE. Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns. Hum Pathol. 2016;57:165–75.
    1. Grossniklaus HE. Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture. JAMA Ophthalmol. 2013;131:462–9.
    1. Meyer Y, Bohlok A, Hoppener D, Galjart B, Doukas M, Grunhagen DJ, et al. Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter studyss. Clin Exp Metastasis. 2022;39:433–42.
    1. Fernandez Moro C, Bozoky B, Gerling M. Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review. BMJ Open Gastroenterol. 2018;5:e000217.
    1. Kwapisz D. Oligometastatic breast cancer. Breast Cancer. 2019;26:138–46.
    1. Tran CG, Sherman SK, Chandrasekharan C, Howe JR. Surgical management of neuroendocrine tumor liver metastases. Surg Oncol Clin N. Am. 2021;30:39–55.
    1. Teng S, Li YE, Yang M, Qi R, Huang Y, Wang Q, et al. Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer. Cell Res. 2020;30:34–49.
    1. Nielsen K, Rolff HC, Eefsen RL, Vainer B. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod Pathol. 2014;27:1641–8.
    1. Eefsen RL, Vermeulen PB, Christensen IJ, Laerum OD, Mogensen MB, Rolff HC, et al. Growth pattern of colorectal liver metastasis as a marker of recurrence risk. Clin Exp Metastasis. 2015;32:369–81.
    1. Kuczynski EA, Yin M, Bar-Zion A, Lee CR, Butz H, Man S, et al. Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma. J Natl Cancer Inst. 2016;108:djw030.
    1. Bridgeman VL, Vermeulen PB, Foo S, Bilecz A, Daley F, Kostaras E, et al. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. J Pathol. 2017;241:362–74.
    1. Leenders WP, Kusters B, Verrijp K, Maass C, Wesseling P, Heerschap A, et al. Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option. Clin Cancer Res. 2004;10:6222–30.
    1. Martens T, Laabs Y, Gunther HS, Kemming D, Zhu Z, Witte L, et al. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2. Clin Cancer Res. 2008;14:5447–58.
    1. Mentha G, Terraz S, Morel P, Andres A, Giostra E, Roth A, et al. Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg. 2009;96:95–103.
    1. Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18:299–304.
    1. Nierop PM, Hoppener DJ, Buisman FE, van der Stok EP, Galjart B, Balachandran VP, et al. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases. J Pathol Clin Res. 2022;8:48–64.
    1. Gomez Dorronsoro ML, Vera R, Ortega L, Plaza C, Miquel R, Garcia M, et al. Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant therapy. Clin Transl Oncol. 2014;16:234–42.
    1. Powley IR, Patel M, Miles G, Pringle H, Howells L, Thomas A, et al. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Br J Cancer. 2020;122:735–44.
    1. Voabil P, de Bruijn M, Roelofsen LM, Hendriks SH, Brokamp S, van den Braber M, et al. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nat Med. 2021;27:1250–61.
    1. Fornabaio G, Barnhill RL, Lugassy C, Bentolila LA, Cassoux N, Roman-Roman S, et al. Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model. Sci Rep. 2018;8:10448.
    1. Latacz E, van Dam PJ, Vanhove C, Llado L, Descamps B, Ruiz N, et al. Can medical imaging identify the histopathological growth patterns of liver metastases? Semin Cancer Biol. 2021;71:33–41.
    1. Wei S, Han Y, Zeng H, Ye S, Cheng J, Chai F, et al. Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy. Eur J Radiol. 2021;142:109863.
    1. Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nat Cell Biol. 2018;20:966–78.
    1. Suzuki K, Tanaka M, Watanabe N, Saito S, Nonaka H, Miyajima A. p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver. Gastroenterology. 2008;135:270–81 e3.
    1. Wells RG. The portal fibroblast: not just a poor man’s stellate cell. Gastroenterology. 2014;147:41–7.
    1. Trim N, Morgan S, Evans M, Issa R, Fine D, Afford S, et al. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol. 2000;156:1235–43.
    1. Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science. 2007;315:1853–6.
    1. Kendall TJ, Hennedige S, Aucott RL, Hartland SN, Vernon MA, Benyon RC, et al. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatology. 2009;49:901–10.
    1. Aimaiti Y, Jin X, Shao Y, Wang W, Li D. Hepatic stellate cells regulate hepatic progenitor cells differentiation via the TGF-beta1/Jagged1 signaling axis. J Cell Physiol. 2019;234:9283–96.
    1. Cassiman D, Denef C, Desmet VJ, Roskams T. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology. 2001;33:148–58.
    1. Vidal-Vanaclocha F, Crende O, Garcia de Durango C, Herreros-Pomares A, Lopez-Domenech S, Gonzalez A, et al. Liver prometastatic reaction: Stimulating factors and responsive cancer phenotypes. Semin Cancer Biol. 2021;71:122–33.
    1. Ciner AT, Jones K, Muschel RJ, Brodt P. The unique immune microenvironment of liver metastases: Challenges and opportunities. Semin Cancer Biol. 2021;71:143–56.
    1. Kurebayashi Y, Kubota N, Sakamoto M. Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: relationship with histopathological and molecular classifications. Hepatol Res. 2021;51:5–18.
    1. Bohlok A, Duran Derijckere I, Azema H, Lucidi V, Vankerckhove S, Hendlisz A, et al. Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases. J Surg Oncol. 2021;123:1773–83.
    1. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science. 2001;294:559–63.
    1. Crivellato E, Nico B, Ribatti D. Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept. J Anat. 2007;211:415–27.
    1. Ding BS, Cao Z, Lis R, Nolan DJ, Guo P, Simons M, et al. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature. 2014;505:97–102.
    1. Daniel E, Cleaver O. Vascularizing organogenesis: lessons from developmental biology and implications for regenerative medicine. Curr Top Dev Biol. 2019;132:177–220.
    1. Muthuswamy SK. Self-organization in cancer: Implications for histopathology, cancer cell biology, and metastasis. Cancer Cell. 2021;39:443–6.
    1. Pezzella F, Di Bacco A, Andreola S, Nicholson AG, Pastorino U, Harris AL. Angiogenesis in primary lung cancer and lung secondaries. Eur J Cancer. 1996;32A:2494–500.
    1. Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Breast cancer progression working party. Lancet. 2000;355:1787–8.
    1. Teuwen LA, De Rooij L, Cuypers A, Rohlenova K, Dumas SJ, Garcia-Caballero M, et al. Tumor vessel co-option probed by single-cell analysis. Cell Rep. 2021;35:109253.
    1. Chen YW, Rini BI. Approaches to first-line therapy for metastatic clear cell renal cell carcinoma. Curr Oncol Rep. 2022;24:695–702.
    1. Sangro B, Sarobe P, Hervás-Stubbs S, Melero I. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:525–43.
    1. Lee JC, Green MD, Huppert LA, Chow C, Pierce RH, Daud AI. The liver-immunity nexus and cancer immunotherapy. Clin Cancer Res. 2022;28:5–12.
    1. Garcia-Vicién G, Mezheyeuski A, Micke P, Ruiz N, Ruffinelli JC, Mils K, et al. Spatial immunology in liver metastases from colorectal carcinoma according to the histologic growth pattern. Cancers. 2022;14:689.
    1. Szczepanski JM, Mendiratta-Lala M, Fang JM, Choi WT, Karamchandani DM, Westerhoff M. Sinusoidal growth pattern of hepatic melanoma metastasis: implications for histopathologic diagnosis. Am J Surg Pathol. 2021;46:832–9.
    1. Li WH, Wang S, Liu Y, Wang XF, Wang YF, Chai RM. Differentiation of histopathological growth patterns of colorectal liver metastases by MRI features. Quant Imaging Med Surg. 2022;12:608–17.
    1. de Ridder JA, Knijn N, Wiering B, de Wilt JH, Nagtegaal ID. Lymphatic invasion is an independent adverse prognostic factor in patients with colorectal liver metastasis. Ann Surg Oncol. 2015;22:S638–45.
    1. Serrablo A, Paliogiannis P, Pulighe F, Moro SS, Borrego-Estella V, Attene F, et al. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases. Eur J Surg Oncol. 2016;42:1268–77.
    1. Fonseca GM, de Mello ES, Faraj SF, Kruger JAP, Coelho FF, Jeismann VB, et al. Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases. J Surg Oncol. 2018;117:1364–75.
    1. Cremolini C, Milione M, Marmorino F, Morano F, Zucchelli G, Mennitto A, et al. Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials. Br J Cancer. 2018;118:955–65.
    1. Falcao D, Alexandrino H, Caetano Oliveira R, Martins J, Ferreira L, Martins R, et al. Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases—pushing growth as an independent risk factor for decreased survival. Eur J Surg Oncol. 2018;44:1212–9.
    1. Ao T, Kajiwara Y, Yonemura K, Shinto E, Mochizuki S, Okamoto K, et al. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases. Virchows Arch. 2019;475:341–8.
    1. Zhang Y, Luo X, Lin J, Fu S, Feng P, Su H, et al. Gelsolin promotes cancer progression by regulating epithelial-mesenchymal transition in hepatocellular carcinoma and correlates with a poor prognosis. J Oncol. 2020;2020:1980368.
    1. Baldin P, Van den Eynde M, Mlecnik B, Bindea G, Beniuga G, Carrasco J, et al. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore. J Pathol Clin Res. 2021;7:27–41.
    1. Temido MJ, Caetano Oliveira R, Martins R, Serodio M, Costa B, Carvalho C, et al. Prognostic factors after hepatectomy for gastric adenocarcinoma liver metastases: desmoplastic growth pattern as the key to improved overall survival. Cancer Manag Res. 2020;12:11689–99.
    1. Jayme VR, Fonseca GM, Amaral IMA, Coelho FF, Kruger JAP, Jeismann VB, et al. Infiltrative tumor borders in colorectal liver metastasis: should we enlarge margin size? Ann Surg Oncol. 2021;28:7636–46.
    1. Zhang YL, He HJ, Cheng J, Shen DH. [Value of histopathological growth pattern in predicting 3-year progression free survival after operation in patients with liver metastasis of colorectal cancer] Zhonghua Bing Li Xue Za Zhi. 2021;50:26–31.
    1. Meyer YM, Beumer BR, Hoppener DJ, Nierop PMH, Doukas M, de Wilde RF, et al. Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinoma. HPB. 2021;24:507–15.
    1. Vles MD, Hoppener DJ, Galjart B, Moelker A, Vermeulen PB, Grunhagen DJ, et al. Local tumour control after radiofrequency or microwave ablation for colorectal liver metastases in relation to histopathological growth patterns. HPB. 2022. online ahead of print.
    1. Ceausu AR, Ciolofan A, Cimpean AM, Magheti A, Mederle O, Raica M. The mesenchymal-epithelial and epithelial-mesenchymal cellular plasticity of liver metastases with digestive origin. Anticancer Res. 2018;38:811–6.
    1. Lazaris A, Amri A, Petrillo SK, Zoroquiain P, Ibrahim N, Salman A, et al. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies. J Pathol Clin Res. 2018;4:184–92.
    1. Wu JB, Sarmiento AL, Fiset PO, Lazaris A, Metrakos P, Petrillo S, et al. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis. World J Gastroenterol. 2019;25:3408–25.
    1. Blank A, Schenker C, Dawson H, Beldi G, Zlobec I, Lugli A. Evaluation of tumor budding in primary colorectal cancer and corresponding liver metastases based on H&E and pancytokeratin staining. Front Med. 2019;6:247.
    1. Palmieri V, Lazaris A, Mayer TZ, Petrillo SK, Alamri H, Rada M, et al. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy. J Pathol. 2020;251:213–23.
    1. Ao T, Kajiwara Y, Yonemura K, Shinto E, Mochizuki S, Okamoto K, et al. Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions. Virchows Arch. 2020;477:47–55.
    1. Rada M, Kapelanski-Lamoureux A, Petrillo S, Tabaries S, Siegel P, Reynolds AR, et al. Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases. Commun Biol. 2021;4:950.
    1. Burren S, Reche K, Blank A, Galvan JA, Dawson H, Berger MD, et al. RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1. Pathol Res Pr. 2021;223:153486.
    1. Donnem T, Reynolds AR, Kuczynski EA, Gatter K, Vermeulen PB, Kerbel RS, et al. Non-angiogenic tumours and their influence on cancer biology. Nat Rev Cancer. 2018;18:323–36.
    1. Baldin P, Van den Eynde M, Hubert C, Jouret-Mourin A, Komuta M. The role of the pathologist and clinical implications in colorectal liver metastasis. Acta Gastroenterol Belg. 2018;81:419–26.
    1. Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Vessel co-option in cancer. Nat Rev Clin Oncol. 2019;16:469–93.
    1. Oliveira RC, Alexandrino H, Cipriano MA, Tralhao JG. Liver metastases and histological growth patterns: biological behavior and potential clinical implications-another path to individualized medicine? J Oncol. 2019;2019:6280347.
    1. Kuczynski EA, Reynolds AR. Vessel co-option and resistance to anti-angiogenic therapy. Angiogenesis. 2020;23:55–74.
    1. Oliveira RC, Alexandrino H, Cipriano MA, Alves FC, Tralhao JG. Predicting liver metastases growth patterns: Current status and future possibilities. Semin Cancer Biol. 2021;71:42–51.
    1. Rigamonti A, Feuerhake F, Donadon M, Locati M, Marchesi F. Histopathological and immune prognostic factors in colorectal liver metastases. Cancers. 2021;13:1075.
    1. Garcia-Vicien G, Mezheyeuski A, Banuls M, Ruiz-Roig N, Mollevi DG. The tumor microenvironment in liver metastases from colorectal carcinoma in the context of the histologic growth patterns. Int J Mol Sci. 2021;22:1544.
    1. Haas G, Fan S, Ghadimi M, De Oliveira T, Conradi LC. Different forms of tumor vascularization and their clinical implications focusing on vessel co-option in colorectal cancer liver metastases. Front Cell Dev Biol. 2021;9:612774.
    1. Rompianesi G, Pegoraro F, Ceresa CD, Montalti R, Troisi RI. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases. World J Gastroenterol. 2022;28:108–22.
    1. Paku S, Lapis K. Morphological aspects of angiogenesis in experimental liver metastases. Am J Pathol. 1993;143:926–36.
    1. Vidal-Vanaclocha F. The prometastatic microenvironment of the liver. Cancer Microenviron. 2008;1:113–29.
    1. Barsky SH, Doberneck SA, Sternlicht MD, Grossman DA, Love SM. ‘Revertant’ DCIS in human axillary breast carcinoma metastases. J Pathol. 1997;183:188–94.
    1. Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest. 2013;123:1887–901.
    1. Dezso K, Papp V, Bugyik E, Hegyesi H, Safrany G, Bodor C, et al. Structural analysis of oval-cell-mediated liver regeneration in rats. Hepatology. 2012;56:1457–67.

Source: PubMed

3
订阅